Stock screener

EBS

Conviction 32HealthcareScan · Thu, Jun 25, 2026
EBS$7.99-5.22%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
6
Vol MA14 1.08M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Emergent BioSolutions Inc.PHARMACEUTICAL PREPARATIONSwww.emergentbiosolutions.com
Price7.99
Change-5.22%
Gap-1.60%
Rel volume2.11×
Avg volume1.04M
Avg $ vol8.52M
SMA 208.24
SMA 508.38
SMA 2009.72
Price vs 50-4.69%
Price vs 200-17.77%
MA stackbearish
50/200 cross
Supertrenddown · 9.25
RSI (14)46
MACD hist-0.00
MACD crossbear · 0d
Stoch %K / %D44 / 60
ADX (14)21
+DI / −DI18 / 25
RSI divergence
MACD divergenceBullish
ATR %+5.75%
ADR %5.47%
52w high13.90
52w low5.63
From 52w high-42.52%
Above 52w low+41.92%
New 52w highNo
SqueezeOff
Bollinger width17.74%
%B0.33
Donchian pos23.37%
Donchian high9.40
Donchian low7.56
AVWAP (52w high)9.28
vs AVWAP high-13.90%
AVWAP (52w low)9.59
vs AVWAP low-16.73%
OBV trendDown
Chaikin MF (20)-0.25
Today vs 20d2.11×
Avg vol (14d)1.08M
Avg vol (20d)1.04M
Avg $ vol (20d)8.52M
Market cap412.25M
RS 3m (vs SPY)-7.01%
RS 6m (vs SPY)-39.86%
RS line new highNo
Trend template2/8
Technical rank20.5
1 week-1.84%
1 month-12.49%
3 months-2.68%
6 months-37.63%
1 year+18.02%
YTD-36.13%
P/E7.84
P/B0.79
P/S0.55
P/FCF2.63
EPS0.9300
Div yield
ROE10.06%
ROA3.98%
Debt/Eq1.10
Current4.29
EV/EBITDA4.21
Gross margin42.75%
Net margin7.08%
Rev growth-28.81%
EPS growth127.60%
Price target12.00
Target upside50.19%
Analyst ratingBuy
Institutional91.54%
Ent. value825.55M
Revenue156.1M
Net income6.8M
Gross profit161.2M
Free cash flow156.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out51.6M
Employees900
ListedWed, Nov 15, 2006
Free float50.61M
Float %98.0%
Short interest9.76M
Days to cover11.5d
Short volume61.2%
Squeeze score93 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction32 / 100
Pattern quality
Tech rank20.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance9.60
Support7.56
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EBS · 1 recent

All disclosures →
MemberSideAmount
Steve Cohen
Steve Cohen
house · D · TN · traded 2024-12-11
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in EBS · 10 sells

InsiderSideShares
Hartzel William
SVP, Bioservices · Common Stock · 2026-06-08
Tax1.74K
Williams Paul Anthony
SVP, Products Business · Common Stock · 2026-06-08
Tax694
LINDAHL RICHARD S
EVP, Chief Financial Officer · Common Stock · 2026-06-08
Tax3.96K
Glessner Coleen
EVP, Quality & Ethics, and CPL · Common Stock · 2026-06-08
Tax2.02K
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell980
Dayal Sujata Tyagi
Director · Common Stock · 2026-05-01
Sell12.78K
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell954
DeGolyer Donald W
Director · Common Stock · 2026-05-01
Sell14.53K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell16.14K
Zoon Kathryn C
Director · Common Stock · 2026-05-01
Sell1.06K

SEC filings

EDGAR filings in EBS

EDGAR →

No recent SEC filings on file for EBS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.